ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Samuels Says Industry Should Pay For Valium Carcinogenicity Tests

March 20, 1981

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010